Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 92.80
+3.20 (3.57%)
Jul 24, 2026, 1:44 PM IDT
Bio-View Financials Overview
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 19.93 | 19.93 | 25.66 | 34.77 | 29.15 | 30.51 |
Revenue Growth | 11.46% | -22.31% | -26.21% | 19.29% | -4.48% | 17.54% |
Gross Profit Gross Profit Growth | 9.52 | 9.52 | 15.56 | 21.38 | 16.67 | 17.59 |
Operating Income Operating Income Growth | -7.75 | -7.75 | -2.97 | 0.14 | 0.1 | 2.56 |
Net Income Net Income Growth | -15.33 | -15.33 | -3.15 | 0.38 | 0.59 | 2.18 |
Earnings Per Share EPS Growth | -1.13 | -1.13 | -0.24 | 0.03 | 0.04 | 0.16 |
EPS Growth | - | - | - | -32.98% | -72.99% | 160.44% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
USA USA Growth | 12.77 | 12.77 | 13.42 | 16.33 | 15.51 | 17.51 |
China China Growth | 1.17 | 1.17 | 5.37 | 11.6 | 5.74 | 3.69 |
Israel Israel Growth | 0.29 | 0.29 | 0.59 | 1.42 | 0.1 | 0.28 |
Other Countries Other Countries Growth | 5.7 | 5.7 | 6.27 | 5.42 | 7.79 | 9.04 |
Total Total Growth | 19.93 | 19.93 | 25.66 | 34.77 | 29.15 | 30.51 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7.22 | 7.22 | 10.94 | 17.11 | 19.44 | 19.22 |
Total Debt Total Debt Growth | 2.79 | 2.79 | 1.98 | 3.51 | 4.06 | 4.61 |
Net Cash (Debt) Net Cash Growth | 4.43 | 4.43 | 8.96 | 13.61 | 15.38 | 14.62 |
Net Cash Growth | -26.02% | -50.59% | -34.17% | -11.52% | 5.23% | -7.36% |
Net Cash Per Share Net Cash Per Share Growth | 0.33 | 0.33 | 0.67 | 0.97 | 1.11 | 1.05 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.06 | -3.06 | -3.11 | 0.15 | 0.97 | 3.25 |
Capital Expenditures CapEx Growth | -0.05 | -0.05 | -0.04 | -0.27 | -0.46 | -0.66 |
Free Cash Flow Free Cash Flow Growth | -3.11 | -3.11 | -3.14 | -0.12 | 0.51 | 2.59 |
Free Cash Flow Growth | - | - | - | - | -80.25% | 419.68% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.76% | 47.76% | 60.66% | 61.48% | 57.20% | 57.63% |
Operating Margin | -38.89% | -38.89% | -11.59% | 0.39% | 0.35% | 8.38% |
Pretax Margin | -45.90% | -45.90% | -11.14% | 2.29% | 3.00% | 8.79% |
Profit Margin | -76.93% | -76.93% | -12.27% | 1.10% | 2.01% | 7.16% |
FCF Margin | -15.60% | -15.60% | -12.24% | -0.35% | 1.75% | 8.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 118.88 | 86.30 | 20.51 |
P/FCF Ratio | - | - | - | - | 99.14 | 17.31 |
PS Ratio | 0.62 | 1.12 | 1.39 | 1.31 | 1.74 | 1.47 |